loading
전일 마감가:
$1.51
열려 있는:
$1.53
하루 거래량:
37,639
Relative Volume:
0.11
시가총액:
$77.79M
수익:
-
순이익/손실:
$-68.96M
주가수익비율:
-0.9294
EPS:
-1.63
순현금흐름:
$-56.62M
1주 성능:
-0.34%
1개월 성능:
-5.91%
6개월 성능:
-13.93%
1년 성능:
-77.42%
1일 변동 폭
Value
$1.50
$1.54
1주일 범위:
Value
$1.47
$1.56
52주 변동 폭
Value
$1.175
$6.87

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
명칭
Pmv Pharmaceuticals Inc
Name
전화
(609) 642-6664
Name
주소
ONE RESEARCH WAY, PRINCETON
Name
직원
63
Name
트위터
Name
다음 수익 날짜
2024-08-07
Name
최신 SEC 제출 서류
Name
PMVP's Discussions on Twitter

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-03-02 업그레이드 Oppenheimer Perform → Outperform
2021-09-22 업그레이드 Goldman Neutral → Buy
2021-08-19 개시 Oppenheimer Perform
2021-08-02 개시 Guggenheim Buy
2021-07-29 개시 H.C. Wainwright Buy
2020-10-20 개시 BofA Securities Buy
2020-10-20 개시 Cowen Outperform
2020-10-20 개시 Evercore ISI Outperform
2020-10-20 개시 Goldman Neutral
모두보기

Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스

pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Australia

Sep 12, 2024
pulisher
Sep 12, 2024

Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com UK

Sep 12, 2024
pulisher
Aug 28, 2024

Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex

Aug 28, 2024
pulisher
Aug 26, 2024

Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Aug 26, 2024
pulisher
Aug 26, 2024

Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World

Aug 26, 2024
pulisher
Aug 25, 2024

Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Aug 25, 2024
pulisher
Aug 22, 2024

PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat

Aug 22, 2024
pulisher
Aug 20, 2024

PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow

Aug 20, 2024
pulisher
Aug 20, 2024

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - StockTitan

Aug 20, 2024
pulisher
Aug 20, 2024

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - GlobeNewswire

Aug 20, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) EPS (Basic) : $-0.97 (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) Purchase Of Investment : $-162.36 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) GF Value Rank : 0 (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Purchases 46,804 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Aug 19, 2024
pulisher
Aug 14, 2024

Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio

Aug 14, 2024
pulisher
Aug 10, 2024

Panasonic (OTCMKTS:PCRFY) Stock Price Crosses Below Fifty Day Moving Average of $9.36 - Defense World

Aug 10, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Initiates Strategic Lease Termination - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Reports Second Quarter 2024 Financial - GlobeNewswire

Aug 08, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

Public Employees Retirement System of Ohio Raises Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Aug 08, 2024
pulisher
Aug 04, 2024

Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Simply Wall St

Aug 04, 2024
pulisher
Aug 02, 2024

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat

Aug 02, 2024
pulisher
Jul 30, 2024

IMNN-01 Plus Perioperative Chemo Improves OS in Newly Diagnosed, Advanced Ovarian Cancer - OncLive

Jul 30, 2024
pulisher
Jul 24, 2024

Acadian Asset Management LLC Increases Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jul 24, 2024
pulisher
Jul 24, 2024

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Acadian Asset Management LLC - MarketBeat

Jul 24, 2024
pulisher
Jul 22, 2024

Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Jul 22, 2024
pulisher
Jul 22, 2024

BNP Paribas Financial Markets Has $597,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

Jul 22, 2024
pulisher
Jul 22, 2024

Mirae Asset Global Investments Co. Ltd. Buys New Stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jul 22, 2024
pulisher
Jul 19, 2024

Rezatapopt Takes Aim at Previously Untargetable p53 Allele to Treat Advanced Solid Tumors - OncLive

Jul 19, 2024
pulisher
Jul 05, 2024

PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 0.6% - Defense World

Jul 05, 2024
pulisher
Jul 05, 2024

PMV Pharmaceuticals (NASDAQ:PMVP) Shares Down 0.6% - MarketBeat

Jul 05, 2024
pulisher
Jul 04, 2024

PMV Pharmaceuticals Inc (PMVP)’s stock chart: A technical perspective - US Post News

Jul 04, 2024
pulisher
Jul 01, 2024

A look into PMV Pharmaceuticals Inc (PMVP)’s deeper side - SETE News

Jul 01, 2024
pulisher
Jun 28, 2024

FDA Approves Tepylute for Breast and Ovarian Cancer Treatment - OncLive

Jun 28, 2024
pulisher
Jun 21, 2024

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

Jun 21, 2024
pulisher
Jun 19, 2024

PMV Pharmaceuticals Inc Inc. (PMVP) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Jun 19, 2024
pulisher
Jun 19, 2024

PMV Pharmaceuticals Inc (PMVP) shows promising results - US Post News

Jun 19, 2024
pulisher
Jun 13, 2024

Views of Wall Street's Leading Experts on PMV Pharmaceuticals Inc – Sete News - SETE News

Jun 13, 2024
pulisher
Jun 11, 2024

Quarterly Snapshot: Quick and Current Ratios for PMV Pharmaceuticals Inc (PMVP) – DWinneX - The Dwinnex

Jun 11, 2024
pulisher
Jun 11, 2024

PMV Pharmaceuticals Inc (PMVP) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News

Jun 11, 2024
pulisher
Jun 08, 2024

AFT Pharmaceuticals Limited (AFP) to Issue Final Dividend of $0.01 on July 3rd - Defense World

Jun 08, 2024
pulisher
Jun 07, 2024

Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher - Yahoo News Malaysia

Jun 07, 2024
pulisher
Jun 05, 2024

PMV Pharmaceuticals Inc (PMVP) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily

Jun 05, 2024
pulisher
Jun 05, 2024

Here's Why You Should Consider Buying Bioventus (BVS) Stock - Yahoo Canada Finance

Jun 05, 2024

Pmv Pharmaceuticals Inc (PMVP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Pmv Pharmaceuticals Inc 주식 (PMVP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
ORBIMED ADVISORS LLC
10% Owner
Nov 22 '23
Sale
2.23
87,786
195,763
0
Mack David Henry
President and CEO
Oct 18 '23
Option Exercise
0.53
198,407
105,156
363,877
$26.55
price down icon 1.28%
$196.11
price down icon 1.22%
$28.98
price down icon 9.71%
$69.58
price up icon 1.94%
$127.27
price up icon 3.16%
$538.98
price up icon 0.25%
자본화:     |  볼륨(24시간):